Upstream Bio, Inc. (UPB)
9.13
+0.04
(+0.44%)
USD |
NASDAQ |
May 11, 16:00
9.13
0.00 (0.00%)
After-Hours: 20:00
Upstream Bio EPS Diluted (Quarterly) : -0.7857 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Janux Therapeutics, Inc. | -0.3888 |
| Evommune, Inc. | -0.6437 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -42.46M |
| Revenue (Quarterly) | 0.668M |
| Total Expenses (Quarterly) | 43.13M |
| Enterprise Value | 154.44M |
| Gross Profit Margin (Quarterly) | 91.47% |
| Profit Margin (Quarterly) | -6.36K% |
| Earnings Yield | -29.17% |
| Normalized Earnings Yield | -29.14 |